BLOG

endpoints

MindMed gains after investigator trial of LSD shows impact on major depression

Shares of MindMed surged Friday morning after researchers who have worked with the company unveiled positive results in a trial using LSD to treat major depressive disorder, running a test similar to the biotech’s trials of its own related compound.